Invitae Stock

Invitae Enterprise Value

Delisted·Aug 7, 2024

The Enterprise Value (EV) of Invitae (NVTAQ) as of Aug 4, 2026 is 90,000.00 USD. In the previous year, Enterprise Value (EV) was 1.05 B USD — a change of -99.99% (lower).

Enterprise Value

90,000.00USD

YoY

-99.99%

Last updated:

Enterprise Value (EV) of Invitae is 2026 90,000.00 USD. Enterprise Value (EV) of Invitae was 2025 1.05 B USD. It decreases by -99.99% lower compared to the previous year.
Access this data via the Eulerpool API

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitae stock

Enterprise Value (EV) of Invitae is 90,000.00 USD in 2026.

Enterprise Value (EV) of Invitae changed from 1.05 B USD to 90,000.00 USD, representing a -99.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Invitae since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Invitae with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Invitae

All Key Metrics — Invitae